Effectiveness of ranibizumab intravitreal injections for exudative age-related macular degeneration treatment: 12-month outcomes.
作者： Małgorzata Figurska , Andrzej Stankiewicz
DOI: 10.12659/MSM.881934
关键词:
摘要: Background The aim of this paper was to evaluate functional and anatomical results intravitreal ranibizumab injections the course exudative age-related macular degeneration (AMD) treatment over a 12-month observation period.
sci-hub.st 参考文章(28)
Luis Arias, Isabel Roman, Cristina Masuet-Aumatell, Marcos J Rubio, Josep M Caminal, Jaume Catala, Octavio Pujol, One-year results of a flexible regimen with ranibizumab therapy in macular degeneration: relationship with the number of injections. Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 31, pp. 1261- 1267 ,(2011) , 10.1097/IAE.0B013E318207D152
Yvonne Chen, Christian Wiesmann, Germaine Fuh, Bing Li, Hans W Christinger, Patrick McKay, Abraham M de Vos, Henry B Lowman, Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen. Journal of Molecular Biology. ,vol. 293, pp. 865- 881 ,(1999) , 10.1006/JMBI.1999.3192
Tryfon Rotsos, Praveen J Patel, Fred K Chen, Adnan Tufail, Initial clinical experience of ranibizumab therapy for neovascular age-related macular degeneration Clinical Ophthalmology. ,vol. 4, pp. 1271- 1275 ,(2010) , 10.2147/OPTH.S14684
Salomon Y. Cohen, Lise Dubois, Ramin Tadayoni, Franck Fajnkuchen, Sylvia Nghiem-Buffet, Corinne Delahaye-Mazza, Brigitte Guiberteau, Gabriel Quentel, Results of One-Year's Treatment with Ranibizumab for Exudative Age-related Macular Degeneration in a Clinical Setting American Journal of Ophthalmology. ,vol. 148, pp. 409- 413 ,(2009) , 10.1016/J.AJO.2009.04.001
Bruce A Keyt, Hung V Nguyen, Lea T Berleau, Carlos M Duarte, Jeanie Park, Helen Chen, Napoleone Ferrara, None, Identification of Vascular Endothelial Growth Factor Determinants for Binding KDR and FLT-1 Receptors GENERATION OF RECEPTOR-SELECTIVE VEGF VARIANTS BY SITE-DIRECTED MUTAGENESIS Journal of Biological Chemistry. ,vol. 271, pp. 5638- 5646 ,(1996) , 10.1074/JBC.271.10.5638
M. S. A. Raja, M. Saldana, C. Goldsmith, B. J. L. Burton, Ranibizumab treatment for neovascular age-related macular degeneration in patients with good baseline visual acuity (better than 6/12): 12-month outcomes British Journal of Ophthalmology. ,vol. 94, pp. 1543- 1545 ,(2010) , 10.1136/BJO.2009.174763
Carsten Framme, Georgios Panagakis, Reginald Birngruber, Effects on choroidal neovascularization after anti-VEGF Upload using intravitreal ranibizumab, as determined by spectral domain-optical coherence tomography. Investigative Ophthalmology & Visual Science. ,vol. 51, pp. 1671- 1676 ,(2010) , 10.1167/IOVS.09-4496
Taha Bandukwala, Rajeev H. Muni, Carol Schwartz, Kenneth T. Eng, Peter J. Kertes, Effectiveness of intravitreal ranibizumab for the treatment of neovascular age-related macular degeneration in a Canadian retina practice: a retrospective review Canadian Journal of Ophthalmology-journal Canadien D Ophtalmologie. ,vol. 45, pp. 590- 595 ,(2010) , 10.3129/I10-082
Richard F. Spaide, The As-Needed Treatment Strategy for Choroidal Neovascularization: A Feedback-Based Treatment System American Journal of Ophthalmology. ,vol. 148, pp. 1- 3 ,(2009) , 10.1016/J.AJO.2009.04.010
P Mitchell, J-F Korobelnik, P Lanzetta, F G Holz, C Prunte, U Schmidt-Erfurth, Y Tano, S Wolf, Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials British Journal of Ophthalmology. ,vol. 94, pp. 2- 13 ,(2010) , 10.1136/BJO.2009.159160